TAUNS Laboratories,Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 197A |
Pharmaceuticals |
Standard |
Daiwa Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. |
2024/05/17 |
2024/06/20 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y430 |
Total Amount |
Y11,156,610,000 |
| IPO Price |
Y460 |
--Company |
Y0 |
Aggregate Value
(based on Initial Price) |
43,000
(Unit:1 million) |
--Leading Shareholder |
Y10,431,430,350 |
| Listed Shares(total) |
24,253,500 |
--Lead Manager |
Y725,179,650 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
15.16 |
Offering Price PBR
(based on previous period) |
5.42 |
| 公開価格PER(今期予想ベース) |
8.29 |
| Initial Price PER |
14.17 |
Initial Price PBR |
5.07 |
| New Shares |
21,090,000 |
Existing Shares |
3,163,500（only O.A.） |
| Shares Outstanding |
Pre IPO |
100,000,000.00 |
PostIPO |
100,000,000.00 |
| Paid Up Capital |
PreIPO |
Y200,000,000 |
PostIPO |
Y200,000,000 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2021/06 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
- |
-54,134 |
-55,111 |
4,679,449 |
| 2022/06 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
17,456,987 |
11,210,685 |
4,480,753 |
7,356,305 |
| 2023/06 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
15,673,099 |
4,953,451 |
3,034,863 |
8,489,871 |
Recent Quarter
2024/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
16,371,691 |
8,249,192 |
5,906,535 |
13,794,508 |
Results Forecast
2024/06 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
17,553,000 |
7,741,000 |
5,550,000 |
- |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2021/06 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-0.55 |
46.71 |
|
| 2022/06 |
Consolidated |
28.00 |
- |
- |
|
| Non-consolidated |
44.81 |
73.48 |
|
| 2023/06 |
Consolidated |
9.00 |
- |
- |
|
| Non-consolidated |
30.35 |
84.80 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2024/03 |
Consolidated |
|
- |
- |
|
| Non-consolidated |
59.07 |
- |
|
Results Forecast
2024/06
| Consolidated
| 27.75 |
- |
- |
|
| Non-consolidated |
55.51 |
- |
|
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 55% |
Daiwa |
03-5555-2111 |
| 25.9% |
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. |
03-6213-8500 |
| 11.1% |
Morgan Stanley MUFG Securities Co., Ltd. |
03-5424-5000 |
| 1.3% |
Mizuho |
03-5208-3210 |
| 1% |
SMBC Nikko |
03-5644-3111 |
| 1% |
Nomura |
03-3211-1811 |
| 1% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| 0.5% |
Shizugin TM |
054‐255‐7511 |
| 0.5% |
ＦＦＧ Securities Co.,Ltd. |
092-771-3836 |
| 0.3% |
aizawa |
03-3272-3118 |
| 0.3% |
IwaiCosmo Securities Co.,Ltd. |
06-6229-2890 |
| 0.3% |
Kyokuto |
03-3667-9171 |
| 0.3% |
Tokai Tokyo |
03-3566-8811 |
| 0.3% |
Toyo |
03-3566-8811 |
| 0.3% |
Marusan |
03-3272-5211 |
| 0.3% |
Matsui |
03-5216-0606 |
| 0.3% |
Monex |
03-4323-3800 |
| 0.3% |
Rakuten Securities |
03-6406-2681 |
| Data |
| Date of incorporation |
2016/04/14 |
| Company address |
Shizuoka 410-2325 |
| Telephone |
0558-76-8181 |
| President |
|
| Homepage |
https://www.tauns.co.jp/ |
| Auditor |
EY Shin Nihon |
|
|
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
55.26% |
| |
30.82% |
| |
5.56% |
| |
2.78% |
| |
0.56% |
| |
0.34% |
| |
0.15% |
| |
0.14% |
| |
0.04% |
| Number of Employees |
272 as of 2024/04/30 |
| Birth Date of Representative |
1975/06/11 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
